MedTrace Logo

Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus

NCT04674332 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 148

Last updated 2021-09-08

No results posted yet for this study

Summary

multiple dose regimen as a standard treatment for gestational diabetes will be compared to long acting insulin

Conditions

  • Long Acting Insulin in Control of Gestational Diabetes Mellitus

Interventions

DRUG

Long acting insulin

long acting insulin analogue once daily at bed time

DRUG

multiple dose regimen

intermediate and short acting insulin

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-12-14
Completion
2020-12-14

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04674332 on ClinicalTrials.gov